Liver Unit, Hospital Clínic, University of Barcelona, Barcelona, Catalunya, Spain; Institut d'Investigacions Biomèdiques August-Pi-Sunyer (IDIBAPS), Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHED), Spain; Instituto Reina Sofia de Investigación Nefrologia (IRSIN), Spain.
Liver Unit, Hospital Clínic, University of Barcelona, Barcelona, Catalunya, Spain; Institut d'Investigacions Biomèdiques August-Pi-Sunyer (IDIBAPS), Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHED), Spain.
J Hepatol. 2012 May;56(5):1040-1046. doi: 10.1016/j.jhep.2011.11.023. Epub 2012 Jan 13.
BACKGROUND & AIMS: Skin and soft tissue infection in cirrhosis is considered a non-severe infection, but specific information is lacking. This study aimed at assessing the characteristics, occurrence of renal failure, and outcome of cirrhotic patients with skin and soft tissue infection.
Ninety-two patients with cirrhosis and skin and soft tissue infection admitted to hospital within a 6-year period were retrospectively analyzed. A control group matched by severity of liver disease, admitted for reasons other than infection, was also studied.
Resolution of the infection was achieved in 96% of patients. Twenty (21.7%) patients with skin and soft tissue infection developed renal failure, compared to only five patients (5.4%) of the control group (p=0.001). Renal failure was persistent despite infection resolution in 10 of the 20 patients vs. none of the control group. Renal failure was associated with poor prognosis. Hyponatremia developed in 40% and 25% of the infection and control group, respectively (p=0.028). Within a 3-month follow-up period, 25 patients (23%) with skin and soft tissue infection died or were transplanted compared to only four patients (4%) of the control group (p<0.001). Factors independently associated with mortality in the infection group were: site of acquisition of the infection and MELD-sodium score at diagnosis.
Skin and soft tissue infection is a severe complication of cirrhosis with high frequency of renal failure and hyponatremia that may persist despite resolution of the infection. MELD-sodium score is useful to assess 3-month mortality in these patients.
肝硬化患者的皮肤和软组织感染被认为是非严重感染,但具体信息尚缺乏。本研究旨在评估肝硬化伴皮肤和软组织感染患者的特征、肾衰竭的发生和结局。
回顾性分析了 6 年内住院的 92 例肝硬化伴皮肤和软组织感染患者。还研究了一组按肝病严重程度匹配、因感染以外的原因住院的对照组。
96%的感染患者治愈。与对照组(5.4%)相比,20 例(21.7%)皮肤和软组织感染患者发生肾衰竭(p=0.001)。尽管感染得到了控制,但在这 20 例患者中有 10 例仍持续存在肾衰竭,而对照组中没有。肾衰竭与不良预后相关。在感染组和对照组中,分别有 40%和 25%的患者出现低钠血症(p=0.028)。在 3 个月的随访期间,25 例(23%)皮肤和软组织感染患者死亡或接受了移植,而对照组仅 4 例(4%)(p<0.001)。感染组死亡的独立相关因素是:感染部位和诊断时的 MELD-钠评分。
皮肤和软组织感染是肝硬化的严重并发症,肾衰竭和低钠血症的发生率较高,尽管感染得到了控制,但仍可能持续存在。MELD-钠评分可用于评估这些患者 3 个月的死亡率。